Rare diseases
Investigational molecules
Locations
Floor 3rd And 4th, Uppsalalaan 17, 3584 CT Utrecht, The Netherlands
Merus B.V. focuses on metastatic and recurrent head and neck squamous cell carcinoma, including PD-L1-expressing disease in the first-line setting and disease that has progressed after prior PD-1 and platinum-based therapy.
Research activity in this area centers on petosemtamab alone and in combination with pembrolizumab.
Merus B.V. runs clinical trials in conditions such as Colorectal cancer metastatic, Neoplasm malignant, Non-small cell lung cancer, Neoplasm, among others.
Clinical trials run by this sponsor – those enrolling participants first.
BelgiumBelgiumBelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
